Search

Department of Oncology

Research Labs

Radiation oncology

BOURHIS Lab

Research

Our focus

Our projects

KEY PUBLICATIONS

UNIL web teasers general.png

People

Meet all the Bourhis Lab Members.

Publications

Publications | Masters and Phd thesis

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

Publications

LOADING...

2021 | 2020 | ...

2021

Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.

Herrera F.G., Ronet C., Ochoa de Olza M., Barras D., Crespo I., Andreatta M., Corria-Osorio J., Spill A., Benedetti F., Genolet R. et al., 2021/09/03. Cancer discovery. Peer-reviewed.

[DOI][Pmid][serval:BIB_D82928F3BB2B]

CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors.

Labiano S., Roh V., Godfroid C., Hiou-Feige A., Romero J., Sum E., Rapp M., Boivin G., Wyss T., Simon C. et al., 2021/07/15. Clinical cancer research, 27 (14) pp. 4054-4065. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_01B309C22867]

Characteristics of very high-energy electron beams for the irradiation of deep-seated targets.

Böhlen T.T., Germond J.F., Traneus E., Bourhis J., Vozenin M.C., Bailat C., Bochud F., Moeckli R., 2021/07. Medical physics, 48 (7) pp. 3958-3967. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6EC1E00C718A]

preview resource BIB_11DA8B398364.P001

Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study.

Rakauskas A., Tawadros T., Lucca I., Herrera F., Bourhis J., Burruni R., Gomes M.N., Codeluppi C., Jolliet L., La Rosa S. et al., 2021/07. Investigative and clinical urology, 62 (4) pp. 416-422. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_11DA8B398364]

Commissioning of an ultra-high dose rate pulsed electron beam medical LINAC for FLASH RT preclinical animal experiments and future clinical human protocols.

Moeckli R., Gonçalves Jorge P., Grilj V., Oesterle R., Cherbuin N., Bourhis J., Vozenin M.C., Germond J.F., Bochud F., Bailat C., 2021/06. Medical physics, 48 (6) pp. 3134-3142. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_04A0655121E7]

Detection of an asymptomatic Covid-19 patient on CBCT-imaging.

Kinj R., Bennassi A., Romano E., Scher N., Bourhis J., Ozsahin M., 2021/03. Radiotherapy and oncology, 156 pp. 199-200. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_F1E31B147F23]

preview resource BIB_C82F89BA6EDB.P001

Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab.

Mampuya W.A., Bouchaab H., Schaefer N., Kinj R., La Rosa S., Letovanec I., Ozsahin M., Bourhis J., Coukos G., Peters S. et al., 2021/03. Clinical and translational radiation oncology, 27 pp. 85-88. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_C82F89BA6EDB]

Anti-Ly6G binding and trafficking mediate positive neutrophil selection to unleash the anti-tumor efficacy of radiation therapy.

Boivin G., Ancey P.B., Vuillefroy de Silly R., Kalambaden P., Contat C., Petit B., Ollivier J., Bourhis J., Meylan E., Vozenin M.C., 2021/02/08. Oncoimmunology, 10 (1) p. 1876597. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_62EF59F96B75]

2020

Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Le Tourneau C., Tao Y., Gomez-Roca C., Cristina V., Borcoman E., Deutsch E., Bahleda R., Calugaru V., Modesto A., Rouits E. et al., 2020/12/15. Clinical cancer research, 26 (24) pp. 6429-6436. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_2A8394CFA639]

Predictive classifier for intensive treatment of head and neck cancer.

Zakeri K., Rotolo F., Lacas B., Vitzthum L.K., Le Q.T., Gregoire V., Overgaard J., Hackshaw A., Zackrisson B., Parmar MKB et al., 2020/12/15. Cancer, 126 (24) pp. 5263-5273. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_760375410F88]

Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.

Benhmida S., Sun R., Gherga E., Hammoud Y., Rouvier J., Mauvais O., Bockel S., Louvrier A., Lebbad A., Bontemps P. et al., 2020/12. Cancer radiotherapie, 24 (8) pp. 812-819. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7FF056BC1846]

An imbalance in competing mortality favouring Debio 1143 - Authors' reply.

Bourhis J., Sun X.S., Tao Y., 2020/11. The Lancet. Oncology, 21 (11) pp. e503. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_61679F8F2A6E]

Percussion assisted radiation therapy in Hodgkin lymphoma allows a marked reduction in heart dose.

Durham A.D., Lovis A., Simons J., Long O., Buela F., Ogna A., Jumeau R., Cairoli A., Rocha Do Carmo Leal S., Zeverino M. et al., 2020/11. Radiotherapy and oncology, 152 pp. 163-168. Peer-reviewed.

[DOI][Pmid][serval:BIB_3318F3D0CA17]

Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH).

Tao Y., Aupérin A., Sun X., Sire C., Martin L., Coutte A., Lafond C., Miroir J., Liem X., Rolland F. et al., 2020/10/24. European journal of cancer, 141 pp. 21-29. Peer-reviewed.

[DOI][Pmid][serval:BIB_0A6D3B3BAF8B]

preview resource BIB_A9F032E17471.P001

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).

Lièvre A., Turpin A., Ray-Coquard I., Le Malicot K., Thariat J., Ahle G., Neuzillet C., Paoletti X., Bouché O., Aldabbagh K. et al., 2020/10/08. European journal of cancer, 141 pp. 62-81. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_A9F032E17471]

High versus low dose irradiation for tumor immune reprogramming.

de Olza M.O., Bourhis J., Irving M., Coukos G., Herrera F.G., 2020/10. Current opinion in biotechnology, 65 pp. 268-283. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_330632946BBD]

Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancers.

Le Guevelou J., Bastit V., Marcy P.Y., Lasne-Cardon A., Guzene L., Gerard M., Larnaudie A., Coutte A., Beddok A., Calugaru V. et al., 2020/10. Radiotherapy and oncology, 151 pp. 256-265. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_120ED9D8B252]

preview resource BIB_C985E6089C8E.P001

Retrospective analysis of the impact of respiratory motion in treatment margins for frameless lung SBRT based on respiratory-correlated CBCT data-sets.

Thengumpallil S., Racine D., Germond J.F., Péguret N., Bourhis J., Bochud F., Moeckli R., 2020/10. Journal of applied clinical medical physics, 21 (10) pp. 170-178. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_C985E6089C8E]

A delivery quality assurance tool based on the actual leaf open times in tomotherapy.

Schopfer M., Bochud F.O., Bourhis J., Moeckli R., 2020/09. Medical physics, 47 (9) pp. 3845-3851. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F8792BD6D01D]

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.

Sun X.S., Tao Y., Le Tourneau C., Pointreau Y., Sire C., Kaminsky M.C., Coutte A., Alfonsi M., Boisselier P., Martin L. et al., 2020/09. The Lancet. Oncology, 21 (9) pp. 1173-1187. Peer-reviewed.

[DOI][Pmid][serval:BIB_351B07FE21EC]

LOADING...

Phd thesis

Publications (3)

Study and modulation of the immune microenvironment in a pre-clinical lung cancer model to optimize radiation-therapy efficiency.

Boivin Gael, Vozenin Marie-Catherine, 2019., Université de Lausanne, Faculté de biologie et médecine, Bourhis Jean (dir.).

[serval:BIB_AB942FA3E259]

preview resource BIB_1C9878253833.P002

Normal Brain, Neural Stem Cells and Glioblastoma Responses to FLASH Irradiation

Montay-Gruel Pierre, 2018/08/24. 258, Université de Lausanne, Faculté de biologie et médecine, Vozenin Marie-Catherine (dir.).

[URN][serval:BIB_1C9878253833]

Epigenetic conséquences and therapeutic implications of ERG transcriptional activation in prostate cancer

Zoma Marita, 2018., Université de Lausanne, Faculté de biologie et médecine, Bourhis Jean (dir.).

[serval:BIB_71C6E011D8B5]

Funding, Resources & Links

Funding	Fondation ISREC Fond’Action Fond National Suisse
Affiliations	Lausanne University Hospital
Links	Biography of Jean Bourhis (UNIL/2013, in French) Interview of Jean Bourhis (UNIL/Faculty of Biology & Medicine/2020, in French) 3 Questions to Jean Bourhis (Lausanne University Hospital/2020, in French) Contributions to Revue Médicale Suisse Media compilation @Planète Santé

Follow us:

CONTACT

Lausanne Oncology BOURHIS lab.png

Jean BOURHIS
Full Professor
Laboratory J. Bourhis

Department of oncology UNIL CHUV

Phone +41 21 314 46 66
Fax +41 21 314 46 01
Email

CONNECT WITH ME

Featured Publication ------------

Xxxxx

Xxxxx | Cell Reports Medicine 02/21

Ch. des Boveresses 155 - CH-1066 Epalinges
Switzerland
Tel. +41 21 692 59 92
Fax +41 21 692 59 95

Contact
Directories

Legal information
Sitemap
Edition

Ludwig Cancer Research

Université de Lausanne

Centre Hospitalier Universitaire Vaudois (CHUV)